Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:AGTC
Delisted

Applied Genetic Technologies Corporation Stock Price (Quote)

$0.397
+0 (+0%)
At Close: Feb 28, 2023

Range Low Price High Price Comment
30 days $0.397 $0.397 Tuesday, 28th Feb 2023 AGTC stock ended at $0.397. During the day the stock fluctuated 0% from a day low at $0.397 to a day high of $0.397.
90 days $0.370 $0.400
52 weeks $0.230 $2.03

Historical Applied Genetic Technologies Corporation prices

Date Open High Low Close Volume
Mar 17, 2016 $13.38 $13.38 $13.38 $13.38 85 400
Mar 16, 2016 $13.30 $13.30 $13.30 $13.30 71 500
Mar 15, 2016 $13.42 $13.42 $13.42 $13.42 106 000
Mar 14, 2016 $14.43 $14.43 $14.43 $14.43 94 500
Mar 11, 2016 $14.20 $14.20 $14.20 $14.20 78 800
Mar 10, 2016 $13.92 $13.92 $13.92 $13.92 106 400
Mar 09, 2016 $14.28 $14.28 $14.28 $14.28 127 900
Mar 08, 2016 $13.99 $13.99 $13.99 $13.99 124 600
Mar 07, 2016 $14.76 $14.76 $14.76 $14.76 62 100
Mar 04, 2016 $14.13 $14.13 $14.13 $14.13 96 000
Mar 03, 2016 $14.46 $14.46 $14.46 $14.46 113 300
Mar 02, 2016 $14.56 $14.56 $14.56 $14.56 141 100
Mar 01, 2016 $13.97 $13.97 $13.97 $13.97 280 700
Feb 29, 2016 $13.27 $13.27 $13.27 $13.27 183 000
Feb 26, 2016 $14.21 $14.21 $14.21 $14.21 124 700
Feb 25, 2016 $13.99 $13.99 $13.99 $13.99 205 800
Feb 24, 2016 $14.85 $14.85 $14.85 $14.85 61 600
Feb 23, 2016 $14.55 $14.55 $14.55 $14.55 115 300
Feb 22, 2016 $15.20 $15.20 $15.20 $15.20 111 100
Feb 19, 2016 $14.75 $14.75 $14.75 $14.75 81 400
Feb 18, 2016 $14.38 $14.38 $14.38 $14.38 176 700
Feb 17, 2016 $14.40 $14.40 $14.40 $14.40 352 200
Feb 16, 2016 $13.94 $13.94 $13.94 $13.94 103 300
Feb 12, 2016 $13.55 $13.55 $13.55 $13.55 127 300
Feb 11, 2016 $12.93 $12.93 $12.93 $12.93 90 000
Click to get the best stock tips daily for free!

About Applied Genetic Technologies Corporation

Applied Genetic Technologies Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials. It is also developing... AGTC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT